Cellebrite DI (CLBT) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to 0.49.
- Cellebrite DI's Equity Ratio rose 65790.42% to 0.49 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.49, marking a year-over-year increase of 65790.42%. This contributed to the annual value of 0.49 for FY2024, which is 65790.42% up from last year.
- Cellebrite DI's Equity Ratio amounted to 0.49 in Q4 2024, which was up 65790.42% from 0.06 recorded in Q4 2023.
- In the past 5 years, Cellebrite DI's Equity Ratio ranged from a high of 0.49 in Q4 2024 and a low of 0.41 during Q3 2021
- Over the past 5 years, Cellebrite DI's median Equity Ratio value was 0.07 (recorded in 2022), while the average stood at 0.05.
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 22328.09% in 2021, then skyrocketed by 65790.42% in 2024.
- Cellebrite DI's Equity Ratio (Quarter) stood at 0.18 in 2020, then tumbled by 223.28% to 0.22 in 2021, then soared by 184.85% to 0.18 in 2022, then plummeted by 64.95% to 0.06 in 2023, then surged by 657.9% to 0.49 in 2024.
- Its Equity Ratio was 0.49 in Q4 2024, compared to 0.06 in Q4 2023 and 0.18 in Q4 2022.